Microsoft The UK regulator has grossly exaggerated the potential damage
Games

Microsoft: The UK regulator has grossly exaggerated the potential damage to Sony from Call of Duty’s transition to Xbox exclusive status

Microsoft doubts the credibility of the core argument of the British Competition and Markets Authority (CMA), which is examining a deal to take over the American publisher Activision Blizzard.

    Image Source: Steam (Kout187)

Image Source: Steam (Kout187)

According to portal axiosLet’s talk about the percentage of gamers willing to give up owning a PlayStation console for an Xbox once the Call of Duty series becomes a Microsoft ecosystem exclusive.

The result of the CMA study on this issue is hidden in the preliminary report, but based on it, the British regulator came to the conclusion that in the event of the loss of the famous shooter franchise “PlayStation is likely to lose a significant share” Audience.

    Image Credit: Activision Blizzard

Image Credit: Activision Blizzard

According to a January YouGov poll commissioned by Microsoft itself, only 3% of all PlayStation owners are willing to switch to Xbox if Call of Duty becomes an American platformer exclusive.

According to Rima Alaily, corporate vice president of Microsoft Legal Counsel, that percentage is (3%) “too small to undermine Sony’s competitiveness and make an Xbox retention strategy viable”.

    Image Source: Steam

Image Source: Steam

Among avid Call of Duty gamers (at least 10 hours or $100 spent on the series in the last year) on PlayStation December CMA survey“Defectors” was 15%, while Microsoft had that figure of 10.5%.

Alayly insists it makes no sense for Microsoft to remove Call of Duty from the PlayStation, though the CMA remains dubious. The final decision on the deal between Microsoft and Activision Blizzard must be made by the British regulator before April 26th.

About the author

Alan Foster

Alan Foster covers computers and games and all the news in the gaming industry.

Add Comment

Click here to post a comment